Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Farnier

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 29, 2008
[Dyslipidemia and abdominal obesity: mechanisms and characteristics (Part I)]M Farnier
International Journal of Clinical Practice|November 12, 2002
Ezetimibe in hypercholesterolaemiaM Farnier
Presse Medicale (Paris, France : 1983)|July 4, 2001
[Hyperlipidemia in the elderly]M Farnier
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1992
[The "duration of administration" factor in studies of clinical pharmacology of hypolipemic drugs]M Farnier
Presse Medicale (Paris, France : 1983)|December 22, 1999
[The hyperlipidemias. Role of various statins]M Farnier
Presse Medicale (Paris, France : 1983)|May 25, 1999
[Dyslipidemia: prevention of cardiovascular risk]M Farnier
The American Journal of Cardiology|September 16, 1998
Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia TreatmentM Farnier
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 29, 2008
[Dyslipidemia and abdominal obesity: therapeutic approaches (Part II)]M Farnier
Idrugs : the Investigational Drugs Journal|August 2, 2005
Synthetic optically pure statinsM Farnier, S Picard
Annales D'Endocrinologie|January 15, 2002
[Obesity and cardiovascular risk]M Krempf, M Farnier
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 29, 2008
[Dyslipidemia and abdominal obesity: mechanisms and characteristics (Part I)]M Farnier
International Journal of Clinical Practice|November 12, 2002
Ezetimibe in hypercholesterolaemiaM Farnier
Presse Medicale (Paris, France : 1983)|July 4, 2001
[Hyperlipidemia in the elderly]M Farnier
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1992
[The "duration of administration" factor in studies of clinical pharmacology of hypolipemic drugs]M Farnier
Presse Medicale (Paris, France : 1983)|December 22, 1999
[The hyperlipidemias. Role of various statins]M Farnier
Presse Medicale (Paris, France : 1983)|May 25, 1999
[Dyslipidemia: prevention of cardiovascular risk]M Farnier
The American Journal of Cardiology|September 16, 1998
Cerivastatin in the treatment of mixed hyperlipidemia: the RIGHT study. The Cerivastatin Study Group. Cerivastatin Gemfibrozil Hyperlipidemia TreatmentM Farnier
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 29, 2008
[Dyslipidemia and abdominal obesity: therapeutic approaches (Part II)]M Farnier
Idrugs : the Investigational Drugs Journal|August 2, 2005
Synthetic optically pure statinsM Farnier, S Picard
Annales D'Endocrinologie|January 15, 2002
[Obesity and cardiovascular risk]M Krempf, M Farnier
Pageof 5